105 related articles for article (PubMed ID: 12506474)
21. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
[TBL] [Abstract][Full Text] [Related]
22. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
23. Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil.
Sakamoto E; Nagase H; Kobunai T; Oie S; Oka T; Fukushima M; Oka T
Biochem Biophys Res Commun; 2007 Nov; 363(1):216-22. PubMed ID: 17854773
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological significance of orotate phosphoribosyltransferase in gastric carcinoma].
Sakurai Y; Yoshida I; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Kamoshida S; Tsutsumi Y
Gan To Kagaku Ryoho; 2006 Apr; 33(4):487-92. PubMed ID: 16612158
[TBL] [Abstract][Full Text] [Related]
25. [Expressions of orotate phosphoribosyltransferase in colorectal carcinoma and its correlations with toxicities of chemotherapy].
Dong Q; Huang S; Li Y; Liu J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1179-81. PubMed ID: 22931617
[TBL] [Abstract][Full Text] [Related]
26. Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma.
Furuse H; Hirano Y; Harada M; Ming LH; Aoki T; Kurita Y; Mugiya S; Ushiyama T; Ozono S
Anticancer Res; 2009 Apr; 29(4):1001-8. PubMed ID: 19414338
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the enzymes associated with 5-fluorouracil metabolism in prostate cancer biopsies.
Tanaka T
Methods Mol Biol; 2011; 755():301-5. PubMed ID: 21761314
[TBL] [Abstract][Full Text] [Related]
28. [Preparation of anti-OPRT antibody for immunochemical detection].
Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
Gan To Kagaku Ryoho; 2005 May; 32(5):653-8. PubMed ID: 15918566
[TBL] [Abstract][Full Text] [Related]
29. Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer.
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Okada T; Ouchi M; Yamada M; Kitajima M; Tsuruoka Y; Takahashi Y; Futagawa S
Oncol Rep; 2005 Oct; 14(4):987-92. PubMed ID: 16142362
[TBL] [Abstract][Full Text] [Related]
30. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
[TBL] [Abstract][Full Text] [Related]
31. [Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].
Sakurai Y; Sakamoto K; Sugimoto Y; Yoshida I; Masui T; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Matsuura S; Tanaka H; Oka T; Fukushima M
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1017-22. PubMed ID: 16044965
[TBL] [Abstract][Full Text] [Related]
32. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas.
Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T
Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501
[TBL] [Abstract][Full Text] [Related]
33. Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen.
Ichikawa W; Takahashi T; Suto K; Sasaki Y; Hirayama R
Clin Cancer Res; 2006 Jul; 12(13):3928-34. PubMed ID: 16818689
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between clinicopathological factors and enzymatic activity of orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD) in esophageal cancer].
Takemura M; Yoshida K; Morimura K; Osugi H; Lee S; Kishida S
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1283-6. PubMed ID: 20647710
[TBL] [Abstract][Full Text] [Related]
35. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
[TBL] [Abstract][Full Text] [Related]
36. Quantitative double-fluorescence immunohistochemistry (qDFIHC), a novel technology to assess protein expression: a pilot study analyzing 5-FU sensitive markers thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferases in gastric cancer tissue specimens.
Kai K; Kitajima Y; Hiraki M; Satoh S; Tanaka M; Nakafusa Y; Tokunaga O; Miyazaki K
Cancer Lett; 2007 Dec; 258(1):45-54. PubMed ID: 17892912
[TBL] [Abstract][Full Text] [Related]
37. [Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1053-6. PubMed ID: 15272584
[TBL] [Abstract][Full Text] [Related]
38. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
[TBL] [Abstract][Full Text] [Related]
39. Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells.
Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
Int J Mol Med; 2005 Aug; 16(2):245-9. PubMed ID: 16012756
[TBL] [Abstract][Full Text] [Related]
40. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
